Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Cash (2019 - 2021)

Historic Change in Cash for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to $19.2 million.

  • Black Diamond Therapeutics' Change in Cash rose 18890.33% to $19.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $31.2 million, marking a year-over-year increase of 12623.7%. This contributed to the annual value of -$19.8 million for FY2024, which is 19177.68% down from last year.
  • According to the latest figures from Q4 2021, Black Diamond Therapeutics' Change in Cash is $19.2 million, which was up 18890.33% from $9.3 million recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Change in Cash registered a high of $202.5 million during Q1 2020, and its lowest value of -$293.2 million during Q2 2020.
  • In the last 3 years, Black Diamond Therapeutics' Change in Cash had a median value of $2.1 million in 2019 and averaged $1.3 million.
  • Data for Black Diamond Therapeutics' Change in Cash shows a peak YoY increase of 304025.84% (in 2020) and a maximum YoY decrease of 568545.78% (in 2020) over the last 5 years.
  • Black Diamond Therapeutics' Change in Cash (Quarter) stood at $76.0 million in 2019, then tumbled by 128.41% to -$21.6 million in 2020, then skyrocketed by 188.9% to $19.2 million in 2021.
  • Its Change in Cash stands at $19.2 million for Q4 2021, versus $9.3 million for Q3 2021 and $23.2 million for Q2 2021.